Just dreaming...and not that they are in danger of doing something that makes sense in Washington, but what if, out of that $4.5 billion a year for the next ten years, they spend $1 billion and bought out the rights to probuphine. Believe me, Braeburn would sell.
Probuphine could then be sold at cost. $600 for four implants (stated cost in Braeburn's S-1 Registration Statement), plus say $200 for distribution, etc. $800 for six months treatment (cheaper than suboxone).
Braeburn and Titan could split the cash per the license agreement. Titan would get its $165 million in milestones, plus 20% or so of the $835 million remaining (call it $167 million) for a final split of $332 million to TTNP and $668 million to Braeburn.
News 
Market Data 
Discover 
AI
